All Stories

  1. Multivalent C2-alkyl trihydroxypiperidine architectures modulate β-glucocerebrosidase activity
  2. Selenoureido-N-alkyl-3,4,5-trihydroxypiperidines: probing their dual-target role in Gaucher disease
  3. Engineering oxaliplatin( iv ) prodrugs with monohaloacetates for redox-responsive and multimodal anticancer activity
  4. Simultaneous Grafting of 3,4,5‐Trihydroxypiperidine Iminosugars Onto Multivalent Scaffolds via Double Reductive Amination Provides New GCase Inhibitors
  5. An Ongoing Search for Multitarget Ligands as Potential Agents for Diabetes Mellitus and Its Long-Term Complications: New Insights into (5-Arylidene-4-oxothiazolidin-3-yl)alkanoic Acid Derivatives
  6. Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulation
  7. Molecular Basis of Pseudomonas syringae pv actinidiae Levansucrase Inhibition by a Multivalent Iminosugar
  8. Rational design and synthesis of novel N-benzylindole-based epalrestat analogs as selective aldose reductase inhibitors: An unexpected discovery of a new glucose-lowering agent (AK-4) acting as a mitochondrial uncoupler
  9. Iminosugar‐Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers
  10. Effect of Bovine Milk Peptides on Cell Inflammation, Proliferation and Differentiation: Milk Potential Benefits Are Preserved in an Unconventional Cow Feeding Strategy
  11. Rumen microbial community and milk quality in Holstein lactating cows fed olive oil pomace as part in a sustainable feeding strategy
  12. Light‐Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological Chaperones
  13. Evidence of Insulin-Sensitizing and Mimetic Activity of the Sesquiterpene Quinone Avarone, a Protein Tyrosine Phosphatase 1B and Aldose Reductase Dual Targeting Agent from the Marine Sponge Dysidea avara
  14. Gold nanoparticles decorated with monosaccharides and sulfated ligands as potential modulators of the lysosomal enzyme N-acetylgalactosamine-6-sulfatase (GALNS)
  15. Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
  16. 3,4,5‐Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers
  17. Identifying Human PTP1B Enzyme Inhibitors from Marine Natural Products: Perspectives for Developing of Novel Insulin-Mimetic Drugs
  18. Insights into Cytotoxic Behavior of Lepadins and Structure Elucidation of the New Alkaloid Lepadin L from the Mediterranean Ascidian Clavelina lepadiformis
  19. Photoswitchable inhibitors of human β-glucocerebrosidase
  20. Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes
  21. Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs
  22. Bioactive Properties of Breads Made with Sourdough of Hull-Less Barley or Conventional and Pigmented Wheat Flours
  23. Enzymatic Inhibitors from Natural Sources: A Huge Collection of New Potential Drugs
  24. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications—A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B
  25. Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment
  26. Antioxidant and anti-inflammatory properties of sourdoughs containing selected Lactobacilli strains are retained in breads
  27. Does Fermentation Really Increase the Phenolic Content in Cereals? A Study on Millet
  28. miR‐210‐3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5‐fluorouracil
  29. Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes
  30. Honey extracts inhibit PTP1B, upregulate insulin receptor expression, and enhance glucose uptake in human HepG2 cells
  31. Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction
  32. Study on a Fermented Whole Wheat: Phenolic Content, Activity on PTP1B Enzyme and In Vitro Prebiotic Properties
  33. LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy
  34. Stereoselective Synthesis of C-2 Alkylated Trihydroxypiperidines: Novel Pharmacological Chaperones for Gaucher Disease
  35. Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc -driven model of colon cancer
  36. Liquid Crystal-Induced Myoblast Alignment
  37. In depth study of phenolic profile and PTP-1B inhibitory power of cold-pressed grape seed oils of different varieties
  38. Multiwalled carbon nanotubes for combination therapy: a biodistribution and efficacy pilot study
  39. Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus
  40. Design, synthesis, in vitro, in vivo and in silico pharmacological characterization of antidiabetic N-Boc-l-tyrosine-based compounds
  41. An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications
  42. Effect of selected strains of lactobacilli on the antioxidant and anti-inflammatory properties of sourdough
  43. LMW-PTP modulates glucose metabolism in cancer cells
  44. Synthesis and evaluation of thiazolidine-2,4-dione/benzazole derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B): Antihyperglycemic activity with molecular docking study
  45. Metformin salts with oxidized multiwalled carbon nanotubes: In vitro biological activity and inhibition of CNT internalization
  46. Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy
  47. Ursolic acid derivatives as potential antidiabetic agents: In vitro , in vivo , and in silico studies
  48. Combined therapies with nanostructured carbon materials: there is room still available at the bottom
  49. Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair
  50. A single amino acid mutation affects elicitor and expansins-like activities of cerato-platanin, a non-catalytic fungal protein
  51. 4-Thiaflavanes as Inhibitors of Amyloid Aggregation
  52. Multiwalled carbon nanotubes for drug delivery: Efficiency related to length and incubation time
  53. Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents
  54. Low molecular weight protein tyrosine phosphatase: Multifaceted functions of an evolutionarily conserved enzyme
  55. In vitro and in silico PTP-1B inhibition and in vivo antidiabetic activity of semisynthetic moronic acid derivatives
  56. Morin: A Promising Natural Drug
  57. The “click-on-tube” approach for the production of efficient drug carriers based on oxidized multi-walled carbon nanotubes
  58. Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)
  59. Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth
  60. 5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
  61. Azido-Substituted BODIPY Dyes for the Production of Fluorescent Carbon Nanotubes
  62. Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease
  63. Effect of Natural Compounds on Insulin Signaling
  64. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition
  65. Tumor Microenvironment and Metabolism in Prostate Cancer
  66. Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells
  67. Anoikis molecular pathways and its role in cancer progression
  68. The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment
  69. Effect of IR laser on myoblasts: a proteomic study
  70. The effects of CA IX catalysis products within tumor microenvironment
  71. Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors
  72. New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells
  73. Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP–1B: In vitro, in silico, and in vivo approaches
  74. Protein N-Homocysteinylation Induces the Formation of Toxic Amyloid-Like Protofibrils
  75. PrPcactivation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway
  76. Structure-Based Optimization of Benzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B and Low Molecular Weight Protein Tyrosine Phosphatase
  77. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity
  78. Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors
  79. 5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors
  80. Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress
  81. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases
  82. Low Molecular Weight Protein Tyrosine Phosphatase and Caveolin-1:  Interaction and Isoenzyme-Dependent Regulation†
  83. Site-directed mutagenesis of two aromatic residues lining the active site pocket of the yeast Ltp1
  84. Insulin Inhibits Platelet-derived Growth Factor-induced Cell Proliferation
  85. The in vivo tyrosine phosphorylation level of yeast immunophilin Fpr3 is influenced by the LMW-PTP Ltp1
  86. A Nucleophilic Catalysis Step is Involved in the Hydrolysis of Aryl Phosphate Monoesters by Human CT Acylphosphatase
  87. Hydrogen Peroxide Triggers the Formation of a Disulfide Dimer of Muscle Acylphosphatase and Modifies Some Functional Properties of the Enzyme
  88. Acylphosphatase possesses nucleoside triphosphatase and nucleoside diphosphatase activities
  89. Acylphosphatase Is a Strong Apoptosis Inducer in HeLa Cell Line
  90. The Contribution of Acidic Residues to the Conformational Stability of Common-Type Acylphosphatase
  91. Thermodynamics and Kinetics of Folding of Common-Type Acylphosphatase:  Comparison to the Highly Homologous Muscle Isoenzyme†
  92. Cloning of murine low molecular weight phosphotyrosine protein phosphatase cDNA: identification of a new isoform
  93. Mechanism of acylphosphatase inactivation by Woodward's reagent K
  94. Common-type acylphosphatase: steady-state kinetics and leaving-group dependence
  95. 2-Methoxybenzoyl phosphate: a new substrate for continuous fluorimetric and spectrophotometric acyl phosphatase assays
  96. Porcine liver low Mr phosphotyrosine protein phosphatase: The amino acid sequence